Table 3.
Binary logistic regression for predictors of adherence to the guideline in the observation phase.
| Variables | Odds ratio | 95% CI | P value |
|---|---|---|---|
| Age ≥ 65 years | 1.087 | 0.34–3.48 | 0.888 |
| Gender (Female vs Male) | 0.220 | 0.06–0.85 | 0.028* |
| STEMI | 0.827 | 0.13–5.33 | 0.841 |
| NSTEMI | 0.846 | 0.12–5.76 | 0.865 |
| Hypertension | 1.676 | 0.18–15.26 | 0.647 |
| Diabetes mellitus | 0.189 | 0.01–3.32 | 0.255 |
| CAD | 1.886 | 0.29–12.29 | 0.507 |
| One comorbidity | 1.609 | 0.014–179.84 | 0.843 |
| ≥2 comorbidities | 0.366 | 0.03–4.04 | 0.412 |
| Taking more than 5 medications | 0.038 | 0.004–0.34 | 0.003* |
Outcome variable = receiving optimal discharge medications ((Aspirin and clopidogrel), statin, ACE-inhibitor or ARB, and β-blocker).
*
Significant (P < 0.05). Female patients and those with polypharmacy are less likely to receive optimal discharge medications. STEMI = ST Segment Elevation Myocardial Infarction; NSTEMI = Non-ST Segment Elevation Myocardial Infarction; CAD = Coronary artery disease.